Current:Home > ContactHow well does a new Alzheimer's drug work for those most at risk? -MoneyMatrix
How well does a new Alzheimer's drug work for those most at risk?
View
Date:2025-04-24 17:12:55
Listen to Short Wave on Spotify, Apple Podcasts and Google Podcasts.
A new drug for Alzheimer's disease, called lecanemab, got a lot of attention earlier this year for getting fast-tracked approval based on a clinical trial that included nearly 1,800 people.
While some saw it as undeniable progress for a disease with no other proven treatment, others urged caution because of severe side effects and the finding of only a "modest" effect. Dr. Jonathan Jackson, Assistant Professor of Neurology at Harvard Medical School, has another concern: the racial and ethnic makeup of the trial.
The clinical trial for lecanemab was the most diverse for an Alzheimer's treatment to date, but it still was not enough to definitively say if the drug is effective for Black people.
"[In] the world's most diverse Alzheimer's trial, a giant trial of 1,800 people that lasted for a much longer time than most trials did, we're still not sure that all of the groups that are at highest risk of Alzheimer's disease actually see any kind of benefit," Jackson, director of the Community Access, Recruitment, and Engagement Research Center, says.
The makers of lecanemab say the trial was able to enroll more Black and Hispanic patients by removing some of the requirements that had been in place for previous trials. They cite tapping into community outreach groups and making it "easy for the patients to enroll into the study, and we made it easy for the patients to actually continue to participate in the study," says Shobha Dhadda, Vice President of Biostatistics and clinical development operations for Neurology at the pharmaceutical company Esai.
The trial enrollment comes close to reaching the racial breakdown of people 65 and older according to the census, but Jackson says that's the wrong goal. Black and Hispanic people, women, and those with a genetic predisposition are all at disproportionately high risk for developing Alzheimer's. Jackson says companies should be overrepresenting these groups in their trials.
"If we continue to study privileged populations ... we're leaving huge questions unanswered about how Alzheimer's works, how it progresses, and what are the significant risk factors," he says. "So when you're designing a study, you should really worry less about the census and more about trying to represent those who are disproportionately affected."
On today's episode, Jonathan and Short Wave co-host Emily Kwong delve into how drug developers can overlook those hardest hit by the disease they're trying to treat.
Have suggestions for what we should cover in future episodes? Email us at shortwave@npr.org.
This episode was produced by Liz Metzger and edited by Gabriel Spitzer. Anil Oza contributed additional reporting and checked the facts. Patrick Murray was the audio engineer.
veryGood! (2)
Related
- Meta releases AI model to enhance Metaverse experience
- Trump denounces verdict as a disgrace and vows this is long from over after felony conviction
- Dolly Parton Gives Her Powerful Take on Beyoncé's Country Album
- Judge to consider recalling death sentence of man who killed 12-year-old Polly Klaas
- 'Malcolm in the Middle’ to return with new episodes featuring Frankie Muniz
- BLM buys about 3,700 acres of land adjacent to Río Grande del Norte National Monument in New Mexico
- A necklace may have saved a man’s life by blocking a bullet
- Nurse fired for calling Gaza war genocide while accepting compassion award
- SFO's new sensory room helps neurodivergent travelers fight flying jitters
- Off the Grid: Sally breaks down USA TODAY's daily crossword puzzle, Late Night
Ranking
- California DMV apologizes for license plate that some say mocks Oct. 7 attack on Israel
- Michelle Troconis hears emotional testimony ahead of sentencing in Jennifer Dulos murder conspiracy
- Chad Daybell guilty of murdering wife, two stepchildren in 'doomsday' case spanning years
- Dramatic video shows Texas couple breaking windshield to save man whose truck was being swallowed in flooded ditch
- Nearly 400 USAID contract employees laid off in wake of Trump's 'stop work' order
- USA gymnastics championships: Brody Malone leads after first night for a major comeback
- Degree attainment rates are increasing for US Latinos but pay disparities remain
- Nurse fired for calling Gaza war genocide while accepting compassion award
Recommendation
What to know about Tuesday’s US House primaries to replace Matt Gaetz and Mike Waltz
Prosecutors unveil cache of Menendez texts in bribery trial: It is extremely important that we keep Nadine happy
Judge to mull overturning Polly Klaas killer Richard Allen Davis' death sentence
World No. 1 Nelly Korda makes a 10 on par-3 12th at 2024 U.S. Women's Open
The White House is cracking down on overdraft fees
Ohio Senate approves fix assuring President Biden is on fall ballot
Clouds, high winds hamper efforts to rescue 2 climbers on North America’s tallest peak
An inflation gauge closely tracked by Federal Reserve rises at slowest pace this year